Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Connaughton Bernadette
Over the trailing 90 days, Connaughton Bernadette (Director at HALOZYME THERAPEUTICS, INC.) sold $232K of stock across 2 companies, per 6 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 6 transactions · CIK 1662521
- Net activity
- −$232K ($0 bought · $232K sold)
By Company (Trailing 90 Days)
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-01 | HALO | Sell | 625 | $48K | Open market or private sale |
| 2026-07-01 | HALO | Sell | 1.0K | $76K | Open market or private sale |
| 2026-06-17 | EDIT | Buy | 51.7K | $0 | Grant, award or other acquisition |
| 2026-06-01 | HALO | Sell | 1.6K | $108K | Open market or private sale |
| 2026-05-05 | HALO | Buy | 6.0K | $0 | Grant, award or other acquisition |
| 2026-05-05 | HALO | Buy | 6.8K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Connaughton's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.